Health Insurance Innovations, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company announced revenues were $63,335,000 compared to $46,108,000 for the same period a year ago. Income from operations was $8,912,000 compared to $6,639,000 for the same period a year ago. Income before income taxes was $8,891,000 compared to $6,714,000 for the same period a year ago. Net income attributable to the company was $3,885,000 compared to $1,939,000 for the same period a year ago. Diluted earnings per share attributable to the company were $0.30 compared to $0.25 for the same period a year ago. EBITDA was $9,917,000 compared to $7,447,000 for the same period a year ago. Adjusted EBITDA was $12,842,000 compared to $8,093,000 for the same period a year ago. Adjusted pre-tax income was $12,293,000 compared to $7,785,000 for the same period a year ago. Adjusted net income was $7,622,000 compared to $4,827,000 for the same period a year ago. Adjusted net income per share was $0.46 compared to $0.33 for the same period a year ago.

For the nine months, the company announced revenues were $180,986,000 compared to $133,092,000 for the same period a year ago. Income from operations was $25,721,000 compared to $14,718,000 for the same period a year ago. Income before income taxes was $25,696,000 compared to $14,191,000 for the same period a year ago. Net income attributable to the company was $14,102,000 compared to $4,701,000 for the same period a year ago. Diluted earnings per share attributable to the company were $1.21 compared to $0.61 for the same period a year ago. EBITDA was $28,652,000 compared to $16,611,000 for the same period a year ago. Adjusted EBITDA was $34,983,000 compared to $18,892,000 for the same period a year ago. Adjusted pre-tax income was $33,527,000 compared to $18,167,000 for the same period a year ago. Adjusted net income was $20,787,000 compared to $11,264,000 for the same period a year ago. Adjusted net income per share was $1.28 compared to $0.77 for the same period a year ago.

Given the record financial performance and long-term prospects, the company is increasing its guidance for the full year 2017.  The company expects revenue to grow 27% to 30% year-over-year with expected revenue of $235 million to $240 million, adjusted EBITDA to grow 48% to 58% year-over-year, with expected adjusted EBITDA of $41 million to $44 million and adjusted EPS to grow 34% to 43%, with expected adjusted EPS of $1.50 to $1.60. The company previously guided to full year revenue of $225 million to $230 million, adjusted EBITDA of $39 million to $42 million and adjusted EPS of $1.45 to $1.55.